Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$772.14 - $960.02 $2.32 Million - $2.88 Million
-3,000 Reduced 32.26%
6,300 $5.58 Million
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $26.5 Million - $33.2 Million
-36,500 Reduced 79.69%
9,300 $8.42 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $10 Million - $13.4 Million
-16,900 Reduced 26.95%
45,800 $35.6 Million
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $7.72 Million - $9.1 Million
14,700 Added 30.63%
62,700 $36.5 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $1.83 Million - $2.52 Million
4,200 Added 9.59%
48,000 $25.8 Million
Q2 2023

Aug 07, 2023

SELL
$350.74 - $468.98 $631,332 - $844,164
-1,800 Reduced 3.95%
43,800 $20.5 Million
Q1 2023

May 08, 2023

BUY
$310.63 - $364.82 $10.3 Million - $12.1 Million
33,200 Added 267.74%
45,600 $15.7 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $225,085 - $262,269
700 Added 5.98%
12,400 $4.54 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $18.2 Million - $20.7 Million
-61,300 Reduced 83.97%
11,700 $3.78 Million
Q2 2022

Aug 03, 2022

SELL
$278.73 - $327.27 $1.09 Million - $1.28 Million
-3,900 Reduced 5.07%
73,000 $23.7 Million
Q1 2022

May 04, 2022

BUY
$234.69 - $291.66 $12.6 Million - $15.7 Million
53,700 Added 231.47%
76,900 $22 Million
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $3.75 Million - $4.66 Million
16,700 Added 256.92%
23,200 $6.41 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $1.44 Million - $1.77 Million
6,500 New
6,500 $1.5 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $1.86 Million - $2.19 Million
-25,000 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
25,000
25,000 $2.06 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.